NGNE (Neurogene Therapeutics) Bozor qiymatining balans qiymatiga nisbati

Neurogene Inc (NGNE) kompaniyasining rasmiy ramzlari

Neurogene Inc. (NGNE) miya xavfsizligini ta'minlash uchun patent himoyasidagi gen faoliyatini boshqarish tizimidan foydalangan holda, aniq gen tuzatish usullarini ishlab chiqishga e'tibor qaratadi. Kompaniyaning resurslari dastlabki bosqichdagi ishlanmalarga yo'naltirilgan bo'lib, bu sinov natijalari bo'yicha yuqori xavflarni yuzaga keltiradi. GURU.Markets platformasida mavjud narx harakati vektori 1.98 hisoblanadi. Moliyaviy muvaffaqiyat kamyob patologiyalar uchun yuqori xarajatli terapiya kurslarini sug'urta kompaniyalariga sotishga asoslangan.

NGNE - neurogene.com Bozor qiymatining balans qiymatiga koeffitsiyenti 21.02.2024 - 28.10.2026 oraligʻida
Neurogene Corp original mahsuloti

AQSh huquqiy bazasining barqarorligi va Neurogene Inc. (NGNE) ishlanmalarining gumanitar maqomi joriy bozor qiymatining buxgalteriya qiymatiga nisbati koeffitsientini kompaniyaning intellektual kapitaliga bozor ishonchining asosiy ko'rsatkichiga aylantiradi. Bozor qiymatini sof aktivlarga bo'lish orqali investor o'sish premiyasini aniqlaydi; sezilarli yuqori og'ish kompaniyaning buxgalteriya qiymatiga nisbatan haddan tashqari qimmat baholanganligidan dalolat beradi.

Raqobatchilar tahlili

Bozor kapitallashuvining balans qiymatiga nisbati BIIB|NBIX (neurocrine.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|BHVN (Biohaven Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Amylyx Pharmaceuticals (AMLX)|Kapitallashuvning balans qiymatiga nisbati trevitherapeutics.com|Praxis Precision Medicines, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Anavex AVXL|Kapitallashuvning sof aktivlarga nisbati CBLL (CeriBell Corp)|Prothena - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Alector Therapeutics (ALEC)|ANNX: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati OMER|AC Immune S.A. (ACIU) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Voyager Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Neumora Corp|Scilex Holding Company - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti TVGN (tevogen.com)|ACOG - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati cogrx.com CGTX|IKT (Inhibikase) - Bozor kapitallashuvining balans qiymatiga nisbati|Cassava Pharma (SAVA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati assertiotx.com ASRT|Coya Therapeutics (COYA) - Balans qiymatiga nisbatan bozor qiymati|VTGN: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi OVID|Bozor qiymatining balans qiymatiga nisbati Acumen Pharma ABOS|Kapitallashuvning balans qiymatiga nisbati CervoMed Corporation (CRVO)|Alterity Therapeutics Limited - Bozor kapitallashuvining balans qiymatiga nisbati|CLNN - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning sof aktivlarga nisbati PEPG (PepGen Corp)|JUNS: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Relmada|Annovis Bio Corporation (ANVS) - Kapitallashuvning balans qiymatiga nisbati|Grace Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati AIFF|Bozor qiymatining balans qiymatiga nisbati Klotho Neurosciences Inc KLTO|Kapitallashuvning balans qiymatiga nisbati neurosense-tx.com (NRSN)|RVPH: Bozor kapitallashuvining balans qiymatiga nisbati|MetaVia Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|NeurAxis, Inc. (NRXS) - Bozor qiymatining balans qiymatiga nisbati|HSDT - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PASG|Bozor qiymatining balans qiymatiga koeffitsiyenti Neuphoria Therapeutics|NERV (Minerva Neurosciences Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ATHA|Addex Therapeutics (ADXN) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ALZN (alzamend.com)|CYCN: Bozor qiymatining balans qiymatiga nisbati|Protagenic Therapeutics Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|Pasithea (KTTA) - Bozor qiymatining balans qiymatiga nisbati|CRGT - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ATXI|Bozor qiymatining balans qiymatiga koeffitsiyenti brainstorm-cell.com|CARA (Cara Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati CHRO|Eliem Therapeutics (ELYM) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ITCI (intracellulartherapies.com)|LBPH: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti marinuspharma.com MRNS|Bozor kapitallashuvining balans qiymatiga nisbati NKGN|NRBO - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SAGE|SNPX (Synaptogenix, Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Trevena, Inc. (TRVN)|Kapitallashuvning balans qiymatiga nisbati Vigil Neuro|Anew Medical, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Cerevel Therapeutics Inc CERE